CS logo
small CS logo
Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases

Vinnytsya, Ukraine
University in Vinnytsia
Pyrohova St, 56, Vinnytsia, Vinnytsia Oblast, 21018

About Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


National Pirogov Memorial Medical University, Vinnytsya is a medical university located in Vinnytsia, Ukraine. It was founded in 1921.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Sunovion
4
ACADIA Pharmaceuticals Inc.
2
Genentech, Inc.
1
Hoffmann-La Roche
1
Total Rows: 4

Clinical Trials at Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


During the past decade, Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years110011330011Started TrialsCompleted Trails20172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
2009-04-01
2013-02-01
Completed
817
A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis
2011-08-31
2022-12-31
Completed
821
Lurasidone Low-Dose - High-Dose Study Study
2013-05-01
2014-06-01
Completed
412
Pediatric Schizophrenia Efficacy and Safety Study
2013-08-01
2015-12-01
Completed
327
Pediatric Open-Label Extension Study
2013-09-30
2018-10-17
Completed
702
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis
2017-09-27
2019-10-30
Completed
392
Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
2019-06-06
2021-02-22
Terminated
235

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSunovion: 4Sunovion: 4ACADIA Pharmaceuticals Inc.: 2ACADIA Pharmaceuticals Inc.: 2Genentech, Inc.: 1Genentech, Inc.: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsRoche Pharma AG: 1Roche Pharma AG: 1

Clinical Trials Conditions at Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


According to Clinical.Site data, the most researched conditions in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases" are "Schizophrenia" (3 trials), "Bipolar Depression" (2 trials), "Adjunctive Treatment of Major Depressive Disorder" (1 trials), "Autism" (1 trials) and "Dementia-related Psychosis" (1 trials). Many other conditions were trialed in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases" in a lesser frequency.

Clinical Trials Intervention Types at Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


Most popular intervention types in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases" are "Drug" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Ocrelizumab" (2 trials), "Avonex" (1 trials), "Interferon beta-1a" (1 trials) and "Interferon beta-1a-matching placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


The vast majority of trials in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases" are 8 trials for "All" genders.

Clinical Trials Status at Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases


Currently, there are NaN active trials in "Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Vin.Reg.Psych.Hosp.N.A Yuschenko O.I., Vnmu N.A. Pyrogov; Department of Nervous Diseases, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 6Completed: 6Active, not recruiting: 1Active, not recruiting: 1Terminated: 1Terminated: 1